CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 417 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04327674
NCT04327674N/ACompleted

The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19

University of Aarhus·observational·Posted Mar 31, 2020·Updated Jun 10, 2024

In Brief

An observational study for COVID-19. Completed, enrolled 417 participants across 2 sites.

Detailed Summary

COVID is a major health problem causing massive capacity problems at hospitals. Rapid and accurate diagnostic workflow is of paramount importance. Access to radiological diagnostics tools such as x-ray or computed tomography of the chest are limited even in high-resource settings. Focused lung ultrasound, FLUS, is a point-of-care diagnostic tool that allows rapid and on-site assessment of lung abnormalities. No transportation of the patient is required thus lowering risk of spreading SAR-CoV- inside the hospital. This study aims to explore the diagnostic value of FLUS in the COVID-19 pandemic and to explore if FLUS findings can predict risk of respiratory failure.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesDenmark
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMar 31, 2020
Enrollment StartMar 14, 2020
Primary CompletionJun 15, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.3 years ago